{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Vancouver",
      "address_1": "14301 Se 1st St",
      "reason_for_recall": "Labeling:Label Mixup; OXcarbazepine Tablet, 600 mg may be potentially mislabeled as    LACTASE ENZYME, Tablet, 3000 units, NDC 24385014976, Pedigree: AD30028_25, EXP: 5/7/2014.",
      "address_2": "",
      "product_quantity": "100 Tablets",
      "code_info": "OXcarbazepine, Tablet, 600 mg has the following code    Pedigree: AD30140_46, EXP: 5/7/2014.",
      "center_classification_date": "20140116",
      "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.",
      "state": "WA",
      "product_description": "OXcarbazepine Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 62756018588",
      "report_date": "20140122",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Aidapak Services, LLC",
      "recall_number": "D-674-2014",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "65707",
      "termination_date": "20140207",
      "more_code_info": "",
      "recall_initiation_date": "20130702",
      "postal_code": "98684-3501",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}